This showed up in my Schwab newsfeed about an hour ago.
Dow Jones - July 1, 2024 2:35 pm
Vitro Biopharma to Offer 1 Million Shares in Initial Public Offering
The regenerative medicine and cellular therapy company expects to price its offering between $5 a share and $6 a share, according to a securities filing. It expects net proceeds around $4.7 million based on a public offering priced at the midpoint of its guidance. Vitro intends to use the net proceeds to advance the continued development of its AlloRx Stem Cell therapy candidate, among other efforts. Vitro said its common stock has been approved for listing on the New York Stock Exchange American under the ticker VTRO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.